beta

AMRS

Amyris Inc.

Amrs

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-13-2018 after market close 08-06-2018 after market close 05-14-2018 after market close 03-15-2018 after market close 11-14-2017 after market close 08-10-2017 after market close 05-15-2017 after market close
Actual EPS -1.67 -0.32 -1.79 -0.17 -1.14 -1.41 -2.1
Consensus EPS -0.17 -0.3 -0.48 0.07 -0.77 -1.11
Estimated EPS -0.17 -0.3 -0.48 0.07 -0.77 -1.11
Number of Estimates 2 2 2 2 2 2 2
EPS Surprise -$1.50 -$0.02 -$1.31 -$0.24 -$0.37 -$0.30

Stats

Summary

Amyris Inc is an industrial biotechnology company engaged in the engineering, manufacturing, and sales of products in markets such as cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels.

Market Cap: 223 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.amyris.com

Shares Outstanding: 43 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.616989

Sector: Basic Materials

Industry: Chemicals

Short Interest (Jan 12, 2018): 2.51 Million

Ethical Flags

Longest drawdown: 1237 trading days

From: 2013-12-30 To: 2018-12-07

Lowest Point:

Amyris announces the sale of convertible notes

via: SeekingAlpha at 2018-12-07 08:59:54:000

Amyris (NASDAQ: AMRS ) has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes in a private placement. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris announces the sale of convertible notes

via: SeekingAlpha at 2018-12-07 08:59:54:000

Amyris (NASDAQ: AMRS ) has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes in a private placement. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris announces the sale of convertible notes

via: SeekingAlpha at 2018-12-07 08:59:54:000

Amyris (NASDAQ: AMRS ) has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes in a private placement. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris announces the sale of convertible notes

via: SeekingAlpha at 2018-12-07 08:59:54:000

Amyris (NASDAQ: AMRS ) has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes in a private placement. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-12-04 12:56:59:000

More news on: Safe-T Group Ltd Sponsored ADR, American Electric Technologies, Inc., Twist Bioscience Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-12-04 12:56:59:000

More news on: Safe-T Group Ltd Sponsored ADR, American Electric Technologies, Inc., Twist Bioscience Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-12-04 12:56:59:000

More news on: Safe-T Group Ltd Sponsored ADR, American Electric Technologies, Inc., Twist Bioscience Corporation, Stocks on the move, , Read more … read more...

Microcaps tops list of midday movers

via: SeekingAlpha at 2018-11-14 12:57:55:000

More news on: Sphere 3D Corp., Tahoe Resources Inc., Empire Resorts, Inc., Stocks on the move, , Read more … read more...

Microcaps tops list of midday movers

via: SeekingAlpha at 2018-11-14 12:57:55:000

More news on: Sphere 3D Corp., Tahoe Resources Inc., Empire Resorts, Inc., Stocks on the move, , Read more … read more...

Microcaps tops list of midday movers

via: SeekingAlpha at 2018-11-14 12:57:55:000

More news on: Sphere 3D Corp., Tahoe Resources Inc., Empire Resorts, Inc., Stocks on the move, , Read more … read more...

Amyris, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-13 22:59:47:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

Amyris, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-13 22:59:47:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

Amyris, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-13 22:59:47:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

Amyris' (AMRS) CEO John Melo on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-13 22:56:03:000

Amyris, Inc. (AMRS) Q3 2018 Earnings Conference Call November 13, 2018 4:30 PM ET Executives Peter DeNardo Director of Investor Relations and Corporate Communications John Melo Chief Executive Officer Kathy Valiasek Chief Financial Officer Analysts … read more...

Amyris' (AMRS) CEO John Melo on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-13 22:56:03:000

Amyris, Inc. (AMRS) Q3 2018 Earnings Conference Call November 13, 2018 4:30 PM ET Executives Peter DeNardo Director of Investor Relations and Corporate Communications John Melo Chief Executive Officer Kathy Valiasek Chief Financial Officer Analysts … read more...

Amyris' (AMRS) CEO John Melo on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-13 22:56:03:000

Amyris, Inc. (AMRS) Q3 2018 Earnings Conference Call November 13, 2018 4:30 PM ET Executives Peter DeNardo Director of Investor Relations and Corporate Communications John Melo Chief Executive Officer Kathy Valiasek Chief Financial Officer Analysts … read more...

Amyris, Wix and Resideo Technologies among after hours movers

via: SeekingAlpha at 2018-11-13 17:36:29:000

More news on: Overseas Shipholding Group, Inc., Kosmos Energy, AXA Equitable Holdings, Stocks on the move, , News on ETFs, Read more … read more...

Amyris misses by $0.46, misses on revenue

via: SeekingAlpha at 2018-11-13 16:03:53:000

Amyris (NASDAQ: AMRS ): Q3 Non-GAAP EPS of -$0.63 misses by $0.46 ; GAAP EPS of -$1.67 misses by $1.50 . Revenue of $14.9M (-38.4% Y/Y) misses by $31.82M . Press Release More news on: Amyris, Inc., Earnings news and commentary, Healthcare stocks news, read more...

Notable earnings after Tuesday's close

via: SeekingAlpha at 2018-11-12 17:35:23:000

AMRS , CWK , HI , HOLI , MTSI , ORIG , REZI , SSTI , SVMK , SWCH , TLRY , VREX , WIX For Seeking Alpha's full earnings season calendar, click here . More news on: Amyris, Inc., Cushman & Wakefield, Hillenbrand, Inc., Earnings news and commentary, , read more...

Amyris Q3 Earnings Preview

via: SeekingAlpha at 2018-11-07 19:00:30:000

Amyris ( AMRS ) is going to report Q3 earnings after the market closes on November 13. The company guides for $185-195M in annual revenue, but has only reported just under $50M in the first half of the year. This is normal for the company, as it ships specialty products in the second half of t… read more...

Amyris Q3 Earnings Preview

via: SeekingAlpha at 2018-11-07 19:00:30:000

Amyris ( AMRS ) is going to report Q3 earnings after the market closes on November 13. The company guides for $185-195M in annual revenue, but has only reported just under $50M in the first half of the year. This is normal for the company, as it ships specialty products in the second half of t… read more...

Amyris Q3 Earnings Preview

via: SeekingAlpha at 2018-11-07 19:00:30:000

Amyris ( AMRS ) is going to report Q3 earnings after the market closes on November 13. The company guides for $185-195M in annual revenue, but has only reported just under $50M in the first half of the year. This is normal for the company, as it ships specialty products in the second half of t… read more...

Amyris Q3 Earnings Preview

via: SeekingAlpha at 2018-11-07 19:00:30:000

Amyris ( AMRS ) is going to report Q3 earnings after the market closes on November 13. The company guides for $185-195M in annual revenue, but has only reported just under $50M in the first half of the year. This is normal for the company, as it ships specialty products in the second half of t… read more...

Twist Bioscience IPO - Love The Company, Hate The Price

via: SeekingAlpha at 2018-10-30 13:58:43:000

Twist Bioscience ( TWST ) is going public this year. The company manufactures and sells DNA molecules with desired code, which is useful for just about anybody working with genetics. First off, I have a confession to make: I love the company. I see it at every synthetic biology event I go to, … read more...

Twist Bioscience IPO - Love The Company, Hate The Price

via: SeekingAlpha at 2018-10-30 13:58:43:000

Twist Bioscience ( TWST ) is going public this year. The company manufactures and sells DNA molecules with desired code, which is useful for just about anybody working with genetics. First off, I have a confession to make: I love the company. I see it at every synthetic biology event I go to, … read more...

Twist Bioscience IPO - Love The Company, Hate The Price

via: SeekingAlpha at 2018-10-30 13:58:43:000

Twist Bioscience ( TWST ) is going public this year. The company manufactures and sells DNA molecules with desired code, which is useful for just about anybody working with genetics. First off, I have a confession to make: I love the company. I see it at every synthetic biology event I go to, … read more...

Week 41 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-10-07 10:47:19:000

Breakout Forecast Selections for Week 41: Week 40 was skipped as I was out of town presenting financial methodologies to graduate and undergraduate finance students at Penn State University. Market conditions have declined significantly since Week 39, with steady declines through the past … read more...

Week 41 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-10-07 10:47:19:000

Breakout Forecast Selections for Week 41: Week 40 was skipped as I was out of town presenting financial methodologies to graduate and undergraduate finance students at Penn State University. Market conditions have declined significantly since Week 39, with steady declines through the past … read more...

Week 41 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-10-07 10:47:19:000

Breakout Forecast Selections for Week 41: Week 40 was skipped as I was out of town presenting financial methodologies to graduate and undergraduate finance students at Penn State University. Market conditions have declined significantly since Week 39, with steady declines through the past … read more...

Amyris inks development deal with Yifan Pharmaceutical; shares up 8% premarket

via: SeekingAlpha at 2018-09-27 09:02:11:000

Amyris (NASDAQ: AMRS ) closes a multiyear agreement with a subsidiary of Chinese outfit Yifan Pharmaceutical Company aimed at developing active pharmaceutical ingredients (APIs), including nutritional products, biologics, small molecule drugs and traditional Chinese medicine, in China and … read more...

Amyris inks development deal with Yifan Pharmaceutical; shares up 8% premarket

via: SeekingAlpha at 2018-09-27 09:02:11:000

Amyris (NASDAQ: AMRS ) closes a multiyear agreement with a subsidiary of Chinese outfit Yifan Pharmaceutical Company aimed at developing active pharmaceutical ingredients (APIs), including nutritional products, biologics, small molecule drugs and traditional Chinese medicine, in China and … read more...

Amyris inks development deal with Yifan Pharmaceutical; shares up 8% premarket

via: SeekingAlpha at 2018-09-27 09:02:11:000

Amyris (NASDAQ: AMRS ) closes a multiyear agreement with a subsidiary of Chinese outfit Yifan Pharmaceutical Company aimed at developing active pharmaceutical ingredients (APIs), including nutritional products, biologics, small molecule drugs and traditional Chinese medicine, in China and … read more...

The Key Risks For Amyris

via: SeekingAlpha at 2018-09-13 14:26:21:000

Since Amyris( AMRS ) is my biggest position, I regularly monitor the risks to the company. One risk that came out of nowhere is Hurricane Florence. Aprinnova, which is probably the biggest JV of Amyris has a plant in Leland, NC. The latest NHC projections show Florence hitting the coast of Nor… read more...

The Key Risks For Amyris

via: SeekingAlpha at 2018-09-13 14:26:21:000

Since Amyris( AMRS ) is my biggest position, I regularly monitor the risks to the company. One risk that came out of nowhere is Hurricane Florence. Aprinnova, which is probably the biggest JV of Amyris has a plant in Leland, NC. The latest NHC projections show Florence hitting the coast of Nor… read more...

The Key Risks For Amyris

via: SeekingAlpha at 2018-09-13 14:26:21:000

Since Amyris( AMRS ) is my biggest position, I regularly monitor the risks to the company. One risk that came out of nowhere is Hurricane Florence. Aprinnova, which is probably the biggest JV of Amyris has a plant in Leland, NC. The latest NHC projections show Florence hitting the coast of Nor… read more...

Amyris Reaches A Critical Stage On Its Path To Rapid EBITDA Growth

via: SeekingAlpha at 2018-09-06 08:00:35:000

The share price of Amyris ( AMRS ) has been surging in 2018 to date, with even recent equity offerings failing to slow it much (see figure). It still has an immense amount of ground to cover to get back to its IPO price (shares are down 96% from that level), but the last year has marked the … read more...

Amyris Reaches A Critical Stage On Its Path To Rapid EBITDA Growth

via: SeekingAlpha at 2018-09-06 08:00:35:000

The share price of Amyris ( AMRS ) has been surging in 2018 to date, with even recent equity offerings failing to slow it much (see figure). It still has an immense amount of ground to cover to get back to its IPO price (shares are down 96% from that level), but the last year has marked the … read more...

Amyris Reaches A Critical Stage On Its Path To Rapid EBITDA Growth

via: SeekingAlpha at 2018-09-06 08:00:35:000

The share price of Amyris ( AMRS ) has been surging in 2018 to date, with even recent equity offerings failing to slow it much (see figure). It still has an immense amount of ground to cover to get back to its IPO price (shares are down 96% from that level), but the last year has marked the … read more...

Premarket Gainers as of 9:05 am (08/30/2018)

via: SeekingAlpha at 2018-08-30 09:19:51:000

KTWO +26% on being acquired by Stryker. More news on: K2M Group Holdings, Inc., Therapix Biosciences, Network-1 Technologies, Inc., Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (08/30/2018)

via: SeekingAlpha at 2018-08-30 09:19:51:000

KTWO +26% on being acquired by Stryker. More news on: K2M Group Holdings, Inc., Therapix Biosciences, Network-1 Technologies, Inc., Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (08/30/2018)

via: SeekingAlpha at 2018-08-30 09:19:51:000

KTWO +26% on being acquired by Stryker. More news on: K2M Group Holdings, Inc., Therapix Biosciences, Network-1 Technologies, Inc., Stocks on the move, , Read more … read more...

Amyris closes $46M equity offering; shares down 1% after hours

via: SeekingAlpha at 2018-08-21 16:35:56:000

Amyris (NASDAQ: AMRS ) has closed its secondary offering of ~7.65M common shares by existing investors at $6.25 per share. Underwriters fully exercised their option to buy an additional 1.15M shares. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more ….. read more...

Amyris closes $46M equity offering; shares down 1% after hours

via: SeekingAlpha at 2018-08-21 16:35:56:000

Amyris (NASDAQ: AMRS ) has closed its secondary offering of ~7.65M common shares by existing investors at $6.25 per share. Underwriters fully exercised their option to buy an additional 1.15M shares. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more ….. read more...

Amyris closes $46M equity offering; shares down 1% after hours

via: SeekingAlpha at 2018-08-21 16:35:56:000

Amyris (NASDAQ: AMRS ) has closed its secondary offering of ~7.65M common shares by existing investors at $6.25 per share. Underwriters fully exercised their option to buy an additional 1.15M shares. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more ….. read more...

Midday Gainers / Losers (08/17/2018)

via: SeekingAlpha at 2018-08-17 12:45:10:000

Gainers: TIK +56% . ZOES +34% . IZEA +28% . CNET +19% . CRMT +18% . YRD +15% . GEMP +13% . PPDF +13% . JWN +12% . ADRO +11% . Losers: ZN -27% . USEG -17% . BOXL -16% . ATGE -15% . DXR -14% . ATAC -14% . AMRS -13% . JMU -14% . ELO… read more...

Midday Gainers / Losers (08/17/2018)

via: SeekingAlpha at 2018-08-17 12:45:10:000

Gainers: TIK +56% . ZOES +34% . IZEA +28% . CNET +19% . CRMT +18% . YRD +15% . GEMP +13% . PPDF +13% . JWN +12% . ADRO +11% . Losers: ZN -27% . USEG -17% . BOXL -16% . ATGE -15% . DXR -14% . ATAC -14% . AMRS -13% . JMU -14% . ELO… read more...

Midday Gainers / Losers (08/17/2018)

via: SeekingAlpha at 2018-08-17 12:45:10:000

Gainers: TIK +56% . ZOES +34% . IZEA +28% . CNET +19% . CRMT +18% . YRD +15% . GEMP +13% . PPDF +13% . JWN +12% . ADRO +11% . Losers: ZN -27% . USEG -17% . BOXL -16% . ATGE -15% . DXR -14% . ATAC -14% . AMRS -13% . JMU -14% . ELO… read more...

Midday Gainers / Losers (08/17/2018)

via: SeekingAlpha at 2018-08-17 12:45:10:000

Gainers: TIK +56% . ZOES +34% . IZEA +28% . CNET +19% . CRMT +18% . YRD +15% . GEMP +13% . PPDF +13% . JWN +12% . ADRO +11% . Losers: ZN -27% . USEG -17% . BOXL -16% . ATGE -15% . DXR -14% . ATAC -14% . AMRS -13% . JMU -14% . ELO… read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2018-08-17 09:12:24:000

ZN -39% on uncertainty over oil production in any commercial quantities. More news on: Zion Oil & Gas Inc, JMU Limited, Amyris, Inc., Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2018-08-17 09:12:24:000

ZN -39% on uncertainty over oil production in any commercial quantities. More news on: Zion Oil & Gas Inc, JMU Limited, Amyris, Inc., Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2018-08-17 09:12:24:000

ZN -39% on uncertainty over oil production in any commercial quantities. More news on: Zion Oil & Gas Inc, JMU Limited, Amyris, Inc., Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2018-08-17 09:12:24:000

ZN -39% on uncertainty over oil production in any commercial quantities. More news on: Zion Oil & Gas Inc, JMU Limited, Amyris, Inc., Stocks on the move, , Read more … read more...

Amyris with 7.4M shares secondary, shares down 12%

via: SeekingAlpha at 2018-08-17 03:11:03:000

Selling shareholders will receive all proceeds from the sale. The underwriter greenshoe is for another 15% shares. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris with 7.4M shares secondary, shares down 12%

via: SeekingAlpha at 2018-08-17 03:11:03:000

Selling shareholders will receive all proceeds from the sale. The underwriter greenshoe is for another 15% shares. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris with 7.4M shares secondary, shares down 12%

via: SeekingAlpha at 2018-08-17 03:11:03:000

Selling shareholders will receive all proceeds from the sale. The underwriter greenshoe is for another 15% shares. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris with 7.4M shares secondary, shares down 12%

via: SeekingAlpha at 2018-08-17 03:11:03:000

Selling shareholders will receive all proceeds from the sale. The underwriter greenshoe is for another 15% shares. More news on: Amyris, Inc., Healthcare stocks news, Read more … read more...

Amyris, Inc. (AMRS) CEO John Melo on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-06 22:25:49:000

Amyris, Inc. (AMRS) Q2 2018 Earnings Conference Call August 6, 2018 4:30 PM ET Executives Peter DeNardo - Director, Investor Relations and Corporate Communications John Melo - Director, President and Chief Executive Officer Kathleen Valiasek - Chief Financial Officer Analysts … read more...

Amyris, Inc. (AMRS) CEO John Melo on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-06 22:25:49:000

Amyris, Inc. (AMRS) Q2 2018 Earnings Conference Call August 6, 2018 4:30 PM ET Executives Peter DeNardo - Director, Investor Relations and Corporate Communications John Melo - Director, President and Chief Executive Officer Kathleen Valiasek - Chief Financial Officer Analysts … read more...

Amyris, Inc. (AMRS) CEO John Melo on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-06 22:25:49:000

Amyris, Inc. (AMRS) Q2 2018 Earnings Conference Call August 6, 2018 4:30 PM ET Executives Peter DeNardo - Director, Investor Relations and Corporate Communications John Melo - Director, President and Chief Executive Officer Kathleen Valiasek - Chief Financial Officer Analysts … read more...

Amyris, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-08-06 21:30:45:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

Amyris, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-08-06 21:30:45:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

Amyris, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-08-06 21:30:45:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

Amyris misses by $0.08, misses on revenue

via: SeekingAlpha at 2018-08-06 16:22:41:000

Amyris (NASDAQ: AMRS ): Q2 EPS of -$0.38 misses by $0.08 . Revenue of $24.8M (-3.4% Y/Y) misses by $12.72M . Shares +3% . Press Release More news on: Amyris, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, read more...

Notable earnings after Monday's close

via: SeekingAlpha at 2018-08-05 17:35:04:000

AEL , AKCA , AMRS , ANDV , ANDX , ANSS , APLE , ARNA , ATSG , AVD , AWR , BHF , BKD , BKH , BRKS , BWXT , CBT , CDEV , CMP , CPE , CRY , CRZO , CVCO , DCO , DPLO , DVAX , EDIT , ETSY , EVBG , FATE , FIVN , FRGI , FRPT , HHC , HTZ , ITRI , KMT , LGND , … read more...

Stocks To Watch: Meet The New Ford

via: SeekingAlpha at 2018-08-04 08:42:14:000

Stocks To Watch: Meet The New Ford Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Investors head into next week with a bit of mo… read more...

B. Riley Financial subsidiaries assist Amyris, Inc. with $36M term loan

via: SeekingAlpha at 2018-07-12 17:59:43:000

B. Riley Financial ( RILY -0.7% ) announced that its operating subsidiaries, B. Riley FBR and Great American Capital Partners, assisted Amyris ( AMRS +2% ) to obtain a $36M term loan. More news on: B. Riley Financial, Inc., Amyris, Inc., Read more … read more...

B. Riley Financial subsidiaries assist Amyris, Inc. with $36M term loan

via: SeekingAlpha at 2018-07-12 17:59:43:000

B. Riley Financial ( RILY -0.7% ) announced that its operating subsidiaries, B. Riley FBR and Great American Capital Partners, assisted Amyris ( AMRS +2% ) to obtain a $36M term loan. More news on: B. Riley Financial, Inc., Amyris, Inc., Read more … read more...

B. Riley Financial subsidiaries assist Amyris, Inc. with $36M term loan

via: SeekingAlpha at 2018-07-12 17:59:43:000

B. Riley Financial ( RILY -0.7% ) announced that its operating subsidiaries, B. Riley FBR and Great American Capital Partners, assisted Amyris ( AMRS +2% ) to obtain a $36M term loan. More news on: B. Riley Financial, Inc., Amyris, Inc., Read more … read more...

Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal

via: SeekingAlpha at 2018-07-01 07:14:07:000

Deals and Financings CStone Pharma of Suzhou acquired rights to a novel cancer drug from Agios (AGIO), a Boston area pharma, in a deal worth up to $424 million (see story ). CStone will have rights to ivosidenib in greater China. It will initially target acute myeloid leukemia ((AML)) and c… read more...

Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal

via: SeekingAlpha at 2018-07-01 07:14:07:000

Deals and Financings CStone Pharma of Suzhou acquired rights to a novel cancer drug from Agios (AGIO), a Boston area pharma, in a deal worth up to $424 million (see story ). CStone will have rights to ivosidenib in greater China. It will initially target acute myeloid leukemia ((AML)) and c… read more...

Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal

via: SeekingAlpha at 2018-07-01 07:14:07:000

Deals and Financings CStone Pharma of Suzhou acquired rights to a novel cancer drug from Agios (AGIO), a Boston area pharma, in a deal worth up to $424 million (see story ). CStone will have rights to ivosidenib in greater China. It will initially target acute myeloid leukemia ((AML)) and c… read more...

Amyris +2.9% after new amendment to loan/security agreement

via: SeekingAlpha at 2018-06-05 18:50:03:000

Amyris (NASDAQ: AMRS ) is up 2.9% in late trading after an 8-K filing indicates it's again amended its loan and security agreement. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Amyris +2.9% after new amendment to loan/security agreement

via: SeekingAlpha at 2018-06-05 18:50:03:000

Amyris (NASDAQ: AMRS ) is up 2.9% in late trading after an 8-K filing indicates it's again amended its loan and security agreement. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Amyris +2.9% after new amendment to loan/security agreement

via: SeekingAlpha at 2018-06-05 18:50:03:000

Amyris (NASDAQ: AMRS ) is up 2.9% in late trading after an 8-K filing indicates it's again amended its loan and security agreement. More news on: Amyris, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Amyris Is Growing Too Fast To Ignore

via: SeekingAlpha at 2018-06-05 15:29:05:000

Amyris ( AMRS ) is an industrial biotechnology company. It genetically engineers yeast, so that instead of producing alcohol when it ferments, yeast produces other valuable chemicals instead. This allows the company to directly produce molecules that are found in nature in small quantities and… read more...

Amyris Is Growing Too Fast To Ignore

via: SeekingAlpha at 2018-06-05 15:29:05:000

Amyris ( AMRS ) is an industrial biotechnology company. It genetically engineers yeast, so that instead of producing alcohol when it ferments, yeast produces other valuable chemicals instead. This allows the company to directly produce molecules that are found in nature in small quantities and… read more...

Amyris Is Growing Too Fast To Ignore

via: SeekingAlpha at 2018-06-05 15:29:05:000

Amyris ( AMRS ) is an industrial biotechnology company. It genetically engineers yeast, so that instead of producing alcohol when it ferments, yeast produces other valuable chemicals instead. This allows the company to directly produce molecules that are found in nature in small quantities and… read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At 19th Annual B. Riley FBR Investor Conference - Slideshow

via: SeekingAlpha at 2018-05-25 13:43:33:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris, Chevron to develop and market renewable base oil technologies

via: SeekingAlpha at 2018-05-18 11:03:43:000

Amyris ( AMRS +4.5% ) moves sharply higher after announcing an agreement with Chevron ( CVX -0.9% ) to jointly develop and market new renewable base oil technologies; financial terms are not disclosed. More news on: Amyris, Inc., Chevron Corporation, Energy stocks news, Stocks on the… read more...

Premarket Gainers as of 9:05 am (5/18/2018)

via: SeekingAlpha at 2018-05-18 09:26:46:000

VLRX +36% on announcing positive results across two new studies evaluating V-Go Insulin Delivery device. More news on: Valeritas Holdings, Inc., Shineco, Inc., SandRidge Mississippian Trust II, Stocks on the move, , Read more … read more...

Biossance Launches Mobile Interactive Clean Beauty Consumer Experience

via: PR Newswire at 2018-05-17 08:30:00:000

Educating Consumers about Clean Beauty in New York City and Toronto NEW YORK , May 17, 2018 /PRNewswire/ --Biossance, the consumer beauty brand from Amyris, Inc. (NASDAQ: AMRS),continues to lead the clean beauty movement with the launch of its new decked-out … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-15 14:05:40:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris' (AMRS) CEO John Melo on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 22:57:06:000

Amyris, Inc. (AMRS) Q1 2018 Earnings Conference Call May 14, 2018 16:30 ET Executives Peter DeNardo - Director, IR & Corporate Communications John Melo - CEO Kathleen Valiasek - CFO Analysts Amit Dayal - H.C. Wainwright Carter Driscoll - B. Riley FBR Presentation … read more...

Amyris misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-05-14 16:15:34:000

Amyris (NASDAQ: AMRS ): Q1 EPS of -$0.52 misses by $0.04 . Revenue of $23M (+77.2% Y/Y) misses by $1.12M . Shares +0.65% . Press Release More news on: Amyris, Inc., Earnings news and commentary, Healthcare stocks news, read more...

Amyris misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-05-14 16:15:34:000

Amyris (NASDAQ: AMRS ): Q1 EPS of -$0.52 misses by $0.04 . Revenue of $23M (+77.2% Y/Y) misses by $1.12M . Shares +0.65% . Press Release More news on: Amyris, Inc., Earnings news and commentary, Healthcare stocks news, read more...

Notable earnings after Monday's close

via: SeekingAlpha at 2018-05-13 17:35:32:000

A , ALTR , AMRS , FENG , HOLI , HTHT , INVH , ITRI , MIME , RXN , SWCH , TDW , VIPS For Seeking Alpha's full earnings season calendar, click here . More news on: Agilent Technologies Inc., Altair Engineering, Inc. Cl A, Amyris, Inc., Earnings news and commentary, , read more...

Notable earnings after Monday's close

via: SeekingAlpha at 2018-05-13 17:35:32:000

A , ALTR , AMRS , FENG , HOLI , HTHT , INVH , ITRI , MIME , RXN , SWCH , TDW , VIPS For Seeking Alpha's full earnings season calendar, click here . More news on: Agilent Technologies Inc., Altair Engineering, Inc. Cl A, Amyris, Inc., Earnings news and commentary, , read more...

Stocks To Watch: A Fed Head Talks Crypto

via: SeekingAlpha at 2018-05-12 09:16:17:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Cryptocurrencies are in the spotlight this week during Blockchain Week in New York … read more...

Stocks To Watch: A Fed Head Talks Crypto

via: SeekingAlpha at 2018-05-12 09:16:17:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Cryptocurrencies are in the spotlight this week during Blockchain Week in New York … read more...

Amyris (AMRS) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

via: SeekingAlpha at 2018-04-10 12:36:44:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

Amyris (AMRS) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

via: SeekingAlpha at 2018-04-10 12:36:44:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

A Shift To Value In The Forensic Algorithm Stock Selections

via: SeekingAlpha at 2018-04-05 06:37:38:000

Forensic Value Stock Selections The following stocks selections using three forensic algorithms (Altman, 1968; Beneish, 1999; Ohlson, 1980) from the financial literature rely exclusively on fundamental data and year over year operational performance measures. The combination of all three ban… read more...

A Shift To Value In The Forensic Algorithm Stock Selections

via: SeekingAlpha at 2018-04-05 06:37:38:000

Forensic Value Stock Selections The following stocks selections using three forensic algorithms (Altman, 1968; Beneish, 1999; Ohlson, 1980) from the financial literature rely exclusively on fundamental data and year over year operational performance measures. The combination of all three ban… read more...

Midday Gainers / Losers (3/16/2018)

via: SeekingAlpha at 2018-03-16 12:45:14:000

Gainers: AMTX +152% . SEED +26% . CVRS +22% . IFMK +22% . TLGT +22% . QBAK +21% . SMRT +21% . ZSAN +21% . AMRS +20% . CTRN +15% . More news on: Aemetis, Inc., Origin Agritech Limited, Corindus Vascular Robotics, Inc., Stocks on the move, , Read more …... read more...

Premarket Gainers as of 9:05 am (1/18/2018)

via: SeekingAlpha at 2018-03-16 09:25:23:000

DXR +29% on positive blood volume analysis data in heart failure patients. More news on: Daxor Corp, Zosano Pharma, Origin Agritech Limited, , Stocks on the move, Read more … read more...

Amyris' (AMRS) CEO John Melo on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-15 21:38:07:000

Amyris, Inc. (AMRS) Q4 2017 Earnings Conference Call March 15, 2018, 04:30 PM ET Executives Peter DeNardo - IR John Melo - CEO Kathy Valiasek - CFO Eduardo Alvarez - COO Analysts Carter Driscoll - FBR Capital Markets Amit Dayal - H.C. Wainwright Presentation Oper… read more...

DSM and Amyris Close Transactions for Brazilian Production Facility

via: PR Newswire at 2017-12-29 08:30:00:000

HEERLEN, Netherlands and EMERYVILLE, California , December 29, 2017 /PRNewswire/ -- Royal DSM (AEX: DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company, today announced that they have… read more...

Amyris Solves Cash Woes With DSM Deal, On Track For 2019 Profitability

via: SeekingAlpha at 2017-12-10 09:07:32:000

After posting Q3 earnings, Amyris ( AMRS ) announced a huge deal with its strategic partner Royal DSM ( RDSMY ). DSM is purchasing Amyris Brasil, a unit of Amyris, which owns and operates its Brotas 1 plant in Brasil. DSM is also buying a license for some of the farnesene IP it is g… read more...

Amyris (AMRS) Special Teleconference on Expanded Strategic Alliance with DSM - Slideshow

via: SeekingAlpha at 2017-11-29 14:05:17:000

The following slide deck was published by Amyris, Inc. in conjunction with this Read more … read more...

DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris

via: PR Newswire at 2017-11-17 09:00:00:000

MILAN , November 17, 2017 /PRNewswire/ -- Royal DSM (AEX: DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company, today announced that they have enhanced their strategic alliance through the… read more...

Amyris' (AMRS) CEO John Melo on Q3 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-14 22:27:02:000

Amyris, Inc. (AMRS) Q3 2017 Earnings Conference Call November 07, 2017, 04:30 PM ET Executives Peter DeNardo - IR John Melo - CEO Kathy Valiasek - CFO Analysts Chris Souther - Cower & Company Amit Dayal - H.C. Wainwright Lisa Springer - Singular Research Carter Dr… read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-11-14 17:35:05:000

Top gainers, as of 5.25 p.m.: SORL +45.2% . CARG +11.5% . WPRT +9.6% . AMRS +7.6% . SYNC +7.5% . More news on: SORL Auto Parts, Inc., CarGurus, Inc., Westport Fuel Systems, Inc., Stocks on the move, Read more … read more...

Amyris, Inc. 2017 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2017-11-14 17:27:27:000

The following slide deck was published by Amyris, Inc. in conjunction with their 2017 Q3 earnings Read more … read more...

Amyris misses by $0.04, misses on revenue

via: SeekingAlpha at 2017-11-14 16:12:13:000

Amyris (NASDAQ: AMRS ): Q3 EPS of -$0.81 misses by $0.04 . Revenue of $24.2M (-8.8% Y/Y) misses by $6.44M . Shares +2.2% . Press Release More news on: Amyris, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Notable earnings after Tuesday's close

via: SeekingAlpha at 2017-11-13 17:35:30:000

AMRS , AST , AUPH , BZH , CRME , ESE , EVOK , FOMX , MTSI , REXX , SITO , SYNC , WPRT , YRD , YY For Seeking Alpha's full earnings season calendar, click here . More news on: Amyris, Inc., Asterias Biotherapeutics, Inc., Aurinia Pharmaceuticals Inc., Earnings news and … read more...

Stocks to watch next week

via: SeekingAlpha at 2017-11-11 09:03:54:000

Key events are scheduled for the companies listed below next week. More news on: Tyson Foods Inc., Progressive Corporation, Kamada Ltd, Consumer stocks news, Energy stocks news, Tech stocks news, Financial stocks news, Healthcare stocks news, Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-06-06 15.0 1.0 15.0
Data provided for free by IEX